10:11 AM EST - HLS Therapeutics Inc. : Will release its Q1 Fiscal 2023 financial results on Thursday, May 11. The Company will hold a conference call that same day at 8:30 a.m. ET to discuss its results. The call will be hosted by Craig Millian, Chief Executive Officer and Tim Hendrickson, Chief Financial Officer. HLS Therapeutics Inc.
shares T.HLS are trading down $0.01 at $5.55.
